Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1771-1780 of 2867 for cancer

Edit search filters
  1. Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With Or Without Bevacizumab In Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ

  2. Once-daily Oral VT-464 In Patients With Castration-Resistant Prostate Cancer Progressing On Enzalutamide Or Abiraterone.

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. PD 0332991 And Anastrozole For Stage 2 Or 3 Estrogen Receptor Positive And HER2 Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study To Evaluate The Safety And Immunological Effect Of Pembrolizumab In Resectable Or Borderline Resectable Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  5. Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer

    Rochester, MN

  6. The Role Of Highly Selective Androgen Receptor (AR) Targeted Therapy In Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. Testing The Addition Of Total Ablative Therapy To Usual Systemic Therapy Treatment For Limited Metastatic Colorectal Cancer, The ERASur Study

    Scottsdale/Phoenix, AZ

  8. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  9. Study Assessing Safety And Efficacy Of Combination Of BL-8040 And Pembrolizumab In Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202)

    Scottsdale/Phoenix, AZ

  10. Intensity-Modulated Radiation Therapy And Paclitaxel With Or Without Pazopanib Hydrochloride In Treating Patients With Anaplastic Thyroid Cancer

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer